Epigenetic regulation of bone remodeling by natural compounds
Authors:
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 147, 104350
Abstract
No abstract availableKeywords
Funding Information
- Schlumberger Foundation
- National Institutes of Health
This publication has 140 references indexed in Scilit:
- Feeding Blueberry Diets in Early Life Prevent Senescence of Osteoblasts and Bone Loss in Ovariectomized Adult Female RatsPLOS ONE, 2011
- Anabolic Agents and Bone QualityClinical Orthopaedics and Related Research, 2011
- Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived CellsJournal of Biological Chemistry, 2011
- Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cellsMolecular Nutrition & Food Research, 2011
- Disorders of Bone RemodelingAnnual Review of Pathology: Mechanisms of Disease, 2011
- Epigenetic targets of bioactive dietary components for cancer prevention and therapyClinical Epigenetics, 2010
- Cellular and Molecular Mechanisms of Bone RemodelingJournal of Biological Chemistry, 2010
- Identification of a Frameshift Mutation in Osterix in a Patient with Recessive Osteogenesis ImperfectaThe American Journal of Human Genetics, 2010
- Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosisThe Journal of Nutritional Biochemistry, 2008
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006